Jump to navigation
Researchers found that the first strain of the flu virus a person encounters during childhood sets the course for how the immune system responds to exposures later in life.
A prestigious $4.5 million MERIT Award from the National Institutes of Health will allow a University of Arizona immunologist to pursue a new, more promising way to study human aging.
The Arizona Prevention Research Center will continue its mission to prevent chronic disease among underserved populations in the Arizona border region thanks to a $7.5 million grant from the CDC.
With a portion of $8 million in annual funding appropriated by the Arizona Legislature, nearly 100 students could receive free tuition at UArizona's two medical schools.
ElectroSonix has licensed the UArizona patents for acoustoelectric imaging, a technology that has the potential to improve the accuracy of cardiac ablation in treating cardiac arrhythmias.
A University of Arizona Health Sciences study funded by a $2.3 million five-year grant from the National Institutes of Health National Eye Institute could help to develop future treatments for glaucoma and other diseases.
UArizona researchers have discovered a protein function that could improve current therapeutic solutions for millions of women who live with genital herpes.
Developed by a research team at the University of Arizona College of Medicine – Phoenix, the self-collection device quickly can evaluate radiation exposure and help triage emergency treatment in the event of a nuclear attack or accident.
The funding will benefit clinical and translational research in the University of Arizona Cancer Center lab of Dr. David Alberts, an expert in ovarian cancer research and treatment.
Preclinical studies have found that Aliskiren, a common blood pressure medication, can prevent fluid retention and muscle wasting in patients with congestive heart failure.